Contact Hours: 1.0

Max CEU Credits: 0.1

Learning Objectives:

On completion of the chapter, the reader will be able to
1. Compare the risk for active tuberculosis disease among patients based on their age, immune status, place of birth, and time since exposure to an active case.
2. Design, evaluate, and assess an appropriate therapeutic plan for an immunocompetent, immunocompromised, pregnant, and pediatric patient.
3. Assess the effectiveness of therapy in tuberculosis patients.
4. Cite the names of the tuberculosis drugs most likely to cause hepatotoxicity.
5. Select patients for whom therapeutic drug monitoring may be valuable.
6. Design, evaluate, and assess appropriate regimens for the treatment of latent tunerculosis infection (LTBI) in all patient populations.
7. Identify the necessary laboratory monitoring parameters for patients on antituberculosis medications.
8. Design a therapeutic plan for a patient with tuberculosis meningitis or tunerculosis osteomyelitis.

Faculty:

ACPE No:
014-999-07-087-H04

---

The University of Georgia College of Pharmacy in on probation as an accredited provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. Next scheduled review for purposes of restoring accreditation or removing accredited provider status: June 2009